Medication in Prison Associated with Reductions in Fatal Opioid Overdoses After Release

A state-led initiative created within the Rhode Island correctional system showed that offering medication to inmates with opioid use disorders reduced fatal overdoses once the inmates were released. The reduction in fatal overdoses was large enough to have a significant effect on the death rate from opioid overdoses statewide. The research was funded by the National Institute on Drug Abuse and the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, as well as the Centers for Disease Control and Prevention.

Every person entering the Rhode Island correctional system was screened for opioid addiction and those who needed it were provided with evidence-based medication assisted treatment (MAT), which included the drugs methadone, buprenorphine, or naltrexone. In addition, a system of 12 community-based Centers of Excellence in MAT were established to continue MAT therapy and provide support after their release from prison or jail.

Full story at drugabuse.gov

Quantum Units Education: New CEU Courses

Opioid Addiction Treatment: Pharmacology of Medications Used

The choice of medication used in medication-assisted treatment (MAT) for opioid addiction is based on safety and efficacy, patient preferences, and treatment goals.  This CE course examines the pharmacology and clinical applications of the principal medications used to treat opioid addiction in opioid treatment programs (OTP).

Management of Major Depressive Disorder in Prison Populations

This CEU course provides recommendations for the management of depression in federal inmates.

For more information on these new courses and many more, visit Quantum Units Education